Sign In
to Vote &
Create Storyboards.
 
FDA shows green light to Zontivity, blood-clot drug that lowers stroke, heart attack risks The U.S. FDA approved Zontivity, a new drug to reduce the risk of stroke, heart attack and death from cardiovascular diseases. Zontivity increases the risk of bleeding and the FDA issues a recommendation on how to safely use it.
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard